Growth Metrics

Merck (MRK) Shareholder's Equity Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.74%
Dec 31, 2025 4.57%
Sep 30, 2025 5.21%
Jun 30, 2025 4.24%
Mar 31, 2025 5.73%
Dec 31, 2024 6.62%
Sep 30, 2024 7.51%
Jun 30, 2024 9.34%
Mar 31, 2024 14.34%
Dec 31, 2023 14.00%
Sep 30, 2023 12.16%
Jun 30, 2023 11.77%
Mar 31, 2023 21.27%
Dec 31, 2022 21.00%
Sep 30, 2022 18.25%
Jun 30, 2022 16.02%
Mar 31, 2022 13.96%
Dec 31, 2021 12.48%
Sep 30, 2021 3.17%
Jun 30, 2021 0.63%
Mar 31, 2021 -7.26%
Dec 31, 2020 -9.76%
Sep 30, 2020 -8.73%
Jun 30, 2020 -11.27%
Mar 31, 2020 528.37%
Dec 31, 2019 -13.60%
Sep 30, 2019 -15.07%
Jun 30, 2019 529.86%
Mar 31, 2019 543.17%
Dec 31, 2018 -15.63%
Sep 30, 2018 -10.58%
Jun 30, 2018 -11.10%
Mar 31, 2018 -10.89%
Dec 31, 2017 -10.85%
Sep 30, 2017 -5.32%
Jun 30, 2017 -6.46%
Mar 31, 2017 -87.37%
Dec 31, 2016 -8.33%
Sep 30, 2016 -4.21%
Jun 30, 2016 -86.96%
Mar 31, 2016 -87.68%
Dec 31, 2015 -6.89%
Sep 30, 2015 -7.76%
Jun 30, 2015 -6.83%
Mar 31, 2015 -5.79%
Dec 31, 2014 -5.02%
Sep 30, 2014 -6.30%
Jun 30, 2014 -5.74%
Mar 31, 2014 -2.57%
Dec 31, 2013 -2.70%
Sep 30, 2013 -4.85%
Jun 30, 2013 -4.57%
Mar 31, 2013 -2.68%
Dec 31, 2012 -3.38%
Sep 30, 2012 31.93%
Jun 30, 2012 36.38%